ziprasidone has been researched along with Cerebral Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, SE; Do, BR; Kaengkan, P; Kam, KY; Kang, SG; Kim, JY; Lee, ES | 1 |
| Choi, YW; Jalin, AM; Kaengkan, P; Kam, KY; Kang, SG; Kim, YH; Park, SW | 1 |
2 other study(ies) available for ziprasidone and Cerebral Ischemia
| Article | Year |
|---|---|
Administration of mesenchymal stem cells and ziprasidone enhanced amelioration of ischemic brain damage in rats.
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cell Survival; Combined Modality Therapy; Disease Models, Animal; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Microglia; Nerve Growth Factor; Neural Stem Cells; Neuroprotective Agents; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles | 2013 |
Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats.
Topics: Animals; Antigens, Nuclear; Antipsychotic Agents; Biomarkers; Brain Injuries; Brain Ischemia; Calcium-Binding Proteins; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Microfilament Proteins; Microglia; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Piperazines; Rats; Rats, Sprague-Dawley; Recovery of Function; Severity of Illness Index; Thiazoles | 2012 |